Sartar Therapeutics Oy

OYActive

Y-tunnus 2754654-8Research and experimental development on natural sciences and engineering· NACE 7210Est. 2016 · 10 years old3 employeessartartherapeutics.com

Overview Financials People & ownership Related companies

Sartar Therapeutics Oy is a Finnish OY, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2016, the company has 3 employees and reported revenue of EUR 0 in its latest annual filing.

Revenue 2025

EUR 0

EBITDA margin

—

Net profit 2025

EUR -951K

-140% vs 2024

Key ratios

See full ratios →

68.7%

This company

20212025

35.7×

This company

20212025

-21.5%

This company

20212025

EBITDA — year on year

EUR millions

Key figures

Annual report 2025

Revenue	EUR 0	—
EBITDA	EUR -473K	-26%
Net profit	EUR -951K	-140%
Total assets	EUR 4,4M	+608%
Equity	EUR 3M	+523%
Employees	3	—

Contact

Address

info@sartartherapeutics.com

Website

sartartherapeutics.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Y-tunnus number of Sartar Therapeutics Oy?

Sartar Therapeutics Oy is registered with PRH / YTJ under Y-tunnus 2754654-8.

How many employees does Sartar Therapeutics Oy have?

Sartar Therapeutics Oy employs 3 people as of the latest annual report.

Who is the CEO of Sartar Therapeutics Oy?

Mikael Maksimow is the CEO of Sartar Therapeutics Oy, in role since 2023.

Who is the chairman of Sartar Therapeutics Oy?

Harri Jaakko Sihto chairs the board of Sartar Therapeutics Oy, in role since 2018.

Sartar Therapeutics Oy

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Sartar Therapeutics Oy

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Sartar Therapeutics Oy